FDA Investigator Sandra L Shire, DMD, MPA
Sandra L Shire, DMD, MPA has conducted inspections on 94 sites in 8 countries as of 15 Dec 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
94
Last Inspection Date:
15 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
France,
Czechia,
Ecuador,
Austria,
Belgium,
Canada,
Italy
FDA Investigators that have inspected at least one site in common with Sandra L Shire, DMD, MPA:
Alexandria L Capuano,
Allen F Hall,
Althea A Williams,
Amanda L Fyles,
Amir Alavi,
Anastasia M Shields,
Angela Shepas,
Armando A Gonzalez,
Armando Chavez, MS,
Binh T Nguyen,
Brian J Ryan,
Brian P Putz,
Byungja E Marciante,
Carla J Lundi,
Carrie A Hughes,
Caryn M Mcnab,
Cathleen A Carr Sharpe,
Cathy L Condon,
Cecilia H Kieu,
Charles L Larson,
Chelsea N Sealey,
Cheryl D Mccall,
Christopher R Czajka,
Cynthia L Rakestraw,
Deborah A Greco,
Devon Jenkins,
Diana M Rand,
Diane Cvan Leeuwen,
Dogbeda F Mackenzie,
Donna Mwilliams Hill, PhD,
Dr. Chunchang Fang,
Elaine A Bunch,
Evelyn Wong,
Garrad R Poole,
Gene D Arcy,
Gerald N Mcgirl, DDS,
James B Arnett,
James D Hildreth,
James R Fleckenstein,
Jennifer M Gogley,
Jocelyn E Massey,
Joel D Hustedt,
Joey V Quitania,
John A Daubenspeck,
John A Gonzalez,
John L Stevens,
Julian C Hanson,
Kaitlyn T Dang,
Kelvin X Sanders,
Kenneth S Boehnen,
Kham Phommachanh,
Kim Lthomas Cruse,
Kimberly M Lichter,
Kirtida Patel,
Laura A Munsterman,
Leonard H Lavi,
Linda Thai,
Lucas B Leake,
Luis P Torres,
Maksim A Levenchuk,
Maria Pkelly Doggett, MBA,
Mark A Tucker,
Mark C Saale,
Marlo Ianm Alintanahin,
Michael D Garcia,
Michelle J Hines,
Nabeela J Chaudhry,
Nelly N Tran,
Nicholas L Hunt,
Paul R Whitby,
Phillip L Toy,
Prabhu P Raju,
Randall N Johnson,
Rebecca Rodriguez,
Richmond K Yip,
Ronda Rloyd Jones,
Scott K Zika,
Sean P Desbrow,
Sidonie J Takougang,
Sonya L Karsik, RAC,
Sundy V Sedwick,
Susan D Yuscius,
Tamal K Chakraborti, PhD,
Tamala P Magee,
Teena H Aiken,
Terri L Dodds,
Terry D Conder,
Thao T Kwan,
Thao X Tran,
Timothy T Kapsala,
Tonia L Sawyer,
Tracey T Duong,
Trudy R Papson,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vickie L Anderson,
Virgilio F Pacio, CSO,
Walden H Lee,
Whitney S Reynolds,
William S Vitale,
Yumi J Hiramine,
Yvette E Guillermo
Sandra L Shire, DMD, MPA's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more